Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study

BACKGROUND: AbobotulinumtoxinA (AboBoNT-A; Dysport(®); Ipsen, Boulogne-Billancourt, France/Azzalure(®); Galderma, Lausanne, Switzerland) is a botulinum neurotoxin type A approved for aesthetic use in the treatment of glabellar lines in adult patients under 65 years in Europe, the United States, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Aesthet Dermatol
Autors principals: Smit, Riekie, Gubanova, Elena, Kaufman, Joely, Landau, Marina, Molina, Beatriz, Andriopoulos, Bill, Maisonobe, Pascal, Prygova, Inna, Redaelli, Alessio
Format: Artigo
Idioma:Inglês
Publicat: Matrix Medical Communications 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8211347/
https://ncbi.nlm.nih.gov/pubmed/34221231
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars